Category: Neurological

Neurological

Outdoor Exposure to Chemical TCE May Raise Risk of Parkinson’s

A large nationwide study finds that long-term exposure to a common industrial chemical in outdoor air is associated with an increased risk of Parkinson’s disease among older adults.

Neurological

New Method Uses Vibration to Diagnose Balance Disorders

Researchers have developed a vibration-based technique to more accurately diagnose balance disorders, especially in aging adults.

Neurological

Q&A: Promoting Patient Physical Activity and Preventing Falls

Deborah Jehu, PhD, highlights strategies for promoting physical activity while preventing falls in older adults.

Brain Injury

NIH Funding Research to Investigate TBI-Dementia Link

An international team of researchers led by Penn Medicine will investigate the link between TBI and dementias over the next five years.

Functional Electrical Stimulation

Stroke Rehab: E-Stim Effect on Hand Choice

Researchers reveal the impact of somatosensory electrical wrist stimulation on influencing hand-choice decision in stroke rehab.

Gait & Balance

Enrollment for Helius Stroke Pivotal Study Exceeds Initial Target

Helius Medical Technologies Inc. has surpassed initial enrollment targets for its stroke registrational program evaluating PoNS Therapy to improve gait and balance.

Multiple Sclerosis

Case Western Reserve Awarded $1M for New MS Treatment Approach Study

A research team at Case Western Reserve University is pioneering a novel approach to multiple sclerosis treatment by targeting toxic astrocytes, with the goal of protecting and regenerating nerve cells.

Strokes

Study: Black Stroke Patients Arrive Later to Hospitals

Black stroke patients arrive later to emergency departments, and EMS is less likely to notify hospitals of their condition ahead of time, a national study shows.

Parkinson’s Disease

Dosing Begins in Solengepras Parkinson’s Therapy Phase 3 Trial

Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras, a non-dopaminergic therapy targeting specific brain circuits, as a potential adjunctive treatment for Parkinson's disease.